Abstract
Skin aging is intrinsic and among the main causes there is the exposure to solar ultraviolet (UV) radiation, which can also lead to skin cancer. The photo-aging or cancer mechanisms include inflammation, oxidative stress from reactive oxygen species (ROS), altered expression of genes, and direct or indirect damage to cellular molecules. The primary inflammatory mediators are interleukin-1 (IL-1), interleukin -6 (IL-6), tumor necrosis factor-alpha (TNF-α) and cycloxygenases (COX)/prostaglandins (PGs). Skin aging and cancer manifests as damage to the extracellular matrix (ECM) composed predominantly of collagen, elastin, and fibrillin. The cells responsible for ECM alterations include epidermal keratinocytes, dermal fibroblasts, and neutrophils. The remodeling of the ECM, primarily as the consequence of inflammation, in skin aging or cancer is from reduced synthesis and increased expression of matrixmetalloproteinases (MMPs). The MMPs degrade the extracellular matrix (ECM) and facilitate metastasis. The predominant classes of MMPs include collagenases (MMP-1, 3) and gelatinases (MMP-2, 9) that degrade the interstitial collagen and basement membrane. In addition, the cellular inhibitors of MMPs, tissue inhibitors of MMPs (TIMPs), and a primary regulator of extracellular matrix (ECM) deposition, transforming growth factor-β (TGF-β), are lowered in skin aging and/or cancer. Polyphenols and flavonoids may be the solution to inflammation associated with skin aging and cancer. P. leucotomos (a tropical fern plant) extract is rich in polyphenols with properties to counteract skin aging mechanisms from its antioxidant and anti-inflammatory properties: it inhibits oxidative stress, lipid peroxidation, dermal mast cell infiltration, inflammatory cytokines, DNA damage, and UV induced tumors. The anti-inflammatory effects of xanthohumol, a flavanoid, include inhibition of COX/PGs and NF-kB transcription factor that is associated with pro-oxidation and inflammation. Further, xanthohumol inhibits nitric oxide production. In addition to the inhibition of inflammatory mediators, polyphenols and flavonoids may stimulate anti-inflammatory mediators such as TGF-β for skin health.
Keywords: Ultraviolet radiation, Inflammation, Extracellular matrix, Transforming growth factor-β, Polypodium leucotomos, Xanthohumol
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Counteraction of Skin Inflammation and Aging or Cancer by Polyphenols and Flavonoids from Polypodium leucotomos and Xanthohumol
Volume: 9 Issue: 2
Author(s): Neena Philips, David Bynum and Hyeondo Hwang
Affiliation:
Keywords: Ultraviolet radiation, Inflammation, Extracellular matrix, Transforming growth factor-β, Polypodium leucotomos, Xanthohumol
Abstract: Skin aging is intrinsic and among the main causes there is the exposure to solar ultraviolet (UV) radiation, which can also lead to skin cancer. The photo-aging or cancer mechanisms include inflammation, oxidative stress from reactive oxygen species (ROS), altered expression of genes, and direct or indirect damage to cellular molecules. The primary inflammatory mediators are interleukin-1 (IL-1), interleukin -6 (IL-6), tumor necrosis factor-alpha (TNF-α) and cycloxygenases (COX)/prostaglandins (PGs). Skin aging and cancer manifests as damage to the extracellular matrix (ECM) composed predominantly of collagen, elastin, and fibrillin. The cells responsible for ECM alterations include epidermal keratinocytes, dermal fibroblasts, and neutrophils. The remodeling of the ECM, primarily as the consequence of inflammation, in skin aging or cancer is from reduced synthesis and increased expression of matrixmetalloproteinases (MMPs). The MMPs degrade the extracellular matrix (ECM) and facilitate metastasis. The predominant classes of MMPs include collagenases (MMP-1, 3) and gelatinases (MMP-2, 9) that degrade the interstitial collagen and basement membrane. In addition, the cellular inhibitors of MMPs, tissue inhibitors of MMPs (TIMPs), and a primary regulator of extracellular matrix (ECM) deposition, transforming growth factor-β (TGF-β), are lowered in skin aging and/or cancer. Polyphenols and flavonoids may be the solution to inflammation associated with skin aging and cancer. P. leucotomos (a tropical fern plant) extract is rich in polyphenols with properties to counteract skin aging mechanisms from its antioxidant and anti-inflammatory properties: it inhibits oxidative stress, lipid peroxidation, dermal mast cell infiltration, inflammatory cytokines, DNA damage, and UV induced tumors. The anti-inflammatory effects of xanthohumol, a flavanoid, include inhibition of COX/PGs and NF-kB transcription factor that is associated with pro-oxidation and inflammation. Further, xanthohumol inhibits nitric oxide production. In addition to the inhibition of inflammatory mediators, polyphenols and flavonoids may stimulate anti-inflammatory mediators such as TGF-β for skin health.
Export Options
About this article
Cite this article as:
Philips Neena, Bynum David and Hwang Hyeondo, Counteraction of Skin Inflammation and Aging or Cancer by Polyphenols and Flavonoids from Polypodium leucotomos and Xanthohumol, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2010; 9 (2) . https://dx.doi.org/10.2174/187152310791110625
DOI https://dx.doi.org/10.2174/187152310791110625 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Application of Phage Display Technology to Cancer Research
Current Pharmaceutical Biotechnology Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
Current Molecular Pharmacology Nanocarrier based Antiretroviral Drug Delivery Approaches
Pharmaceutical Nanotechnology Silencing of Disease-related Genes by Small Interfering RNAs
Current Molecular Medicine The Pivotal Role of Nitric Oxide: Effects on the Nervous and Immune Systems
Current Pharmaceutical Design Deep Learning Approaches Towards Skin Lesion Segmentation and Classification from Dermoscopic Images - A Review
Current Medical Imaging Bioinformatics and Drug Discovery
Current Topics in Medicinal Chemistry Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs
Current Medicinal Chemistry Iron Chelators in Medicinal Applications - Chemical Equilibrium Considerations in Pharmaceutical Activity
Current Medicinal Chemistry Patents and the Development on Polymer based Nanomaterial (PAMAM Dendrimer) for Biomedical Applications
Recent Patents on Biomedical Engineering (Discontinued) Gene Therapeutic Approaches for Immune Modulation in AIDS
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Peroxisome Proliferator-Activated Receptor (PPAR) in Regenerative Medicine: Molecular Mechanism for PPAR in Stem Cells’ Adipocyte Differentiation
Current Stem Cell Research & Therapy The Epidermal Growth Factor Receptor as a Therapeutic Target in Glioblastoma Multiforme and other Malignant Neoplasms
Anti-Cancer Agents in Medicinal Chemistry Quantifying Gp96/Grp94 Complexes Preparations for Vaccines: a Key Step Often Inaccurate
Current Medicinal Chemistry Functionalized magnetic nanoparticles for biomedical applications
Current Pharmaceutical Design Glycoconjugates in Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Baculovirus Gene Delivery: A Flexible Assay Development Tool
Current Gene Therapy Preface: A New Era of Nanoimmunology
Current Pharmaceutical Biotechnology DNA Repair Proteins as Molecular Targets for Cancer Therapeutics
Anti-Cancer Agents in Medicinal Chemistry Radioiodinated Agents for Imaging Multidrug Resistant Tumors
Medicinal Chemistry